Bavarian Nordic A/S

Two European pharmaceutical companies brought the first-quarter earnings season for big cap pharma companies to a close. Although there were hints at the pressures from the first quarter, they appeare

The European Medicines Agency has temporarily suspended the use of Valneva’s chikungunya vaccine, Ixchiq, in individuals over 65 years old following reports of serious adverse events in elderly people

The Centers for Disease Control and Prevention’s Advisory Committee on Immunization Practices sprinted through a condensed two-day schedule at its 15-16 April meeting, which originally had been planne

The Advisory Committee on Immunization Practices’ first meeting under the Trump Administration provided an early public look at concerns that a top FDA official has about vaccine efficacy, safety and